Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectors – Endpoints News
Endpoints News |
Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectors
Endpoints News A gene therapy company headed up by bigwigs and backed early on by Atlas has pulled in a mega-round of $100 million. The 2-year-old startup captured investors' attention by suggesting it knows a better way to do gene transfer than the potentially toxic … Fidelity gets in on $100M round for gene therapy startup Generation Bio Generation Bio Announces $100 Million Series B Financing to Advance GeneWave™ Platform for Re-Dosable Gene … |
